Conventional meat production contributes to 15% of the global greenhouse gas emissions, high energy consumption and land use change. Belgian Paleo NV produces alternative protein from myoglobins of different species.
Generic and biosimilar manufacturer Sandoz is expanding with a new biologics production facility in Lendava, Slovenia to prepare for more demand in Europe for biosimilar products.
The Sweden Biobank Act governs the collection, storage, and usage of identifiable human material samples for specific purposes.
Alentis is the only company developing potential treatments for solid cancers and fibrosis targeting Claudin-1 (CLDN1). The molecule is significantly involved in the tight junction between cells. Now the company closed a three digit million Seriec C round.
From bacteria to cellulose fibers and lab grown paper. A greek project paves the way to save trees.
Tilos marks the first island to achieve 100% diversion from landfill with an 87% recycling rate.
The new Krakow headquarters of preclinical CRO Selvita have opened.
3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing for biological drugs advances its international expansion with the opening of its first commercial office in the United States located in Boston, Massachusetts.
How to stop the silent pandemic AMR was discussed by 500 experts from 13 countries at the 7th AMR Conference in Basel. At that time, in Brussels, there were two proposals on the table on how to compensate novel resistance-breaking antimicrobials, from which one got the green light in the new pharma legislation.
At the IZB, we are right in the middle of it allas one of the leading cell culture specialists in the heart of Germanys biotech hotspot and as a medium manufacturer in life science research.